HAL vs IBIO · P/E 9.3, $19.05B cap vs rev $100.0K
Halliburton Company (HAL) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the HAL and IBIO stock pages for the full models.
Not investment advice.